HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.
Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, te Meerman GJ, van den Berg A.
Niens M, et al. Among authors: diepstra a.
Blood. 2007 Nov 1;110(9):3310-5. doi: 10.1182/blood-2007-05-086934. Epub 2007 Jul 13.
Blood. 2007.
PMID: 17630352
Free article.